Literature DB >> 3287869

Pneumatosis intestinalis after bone marrow transplantation.

D L Day1, N K Ramsay, J G Letourneau.   

Abstract

The clinical and pathologic data in 18 patients in whom pneumatosis intestinalis developed after bone marrow transplantation were reviewed to determine the significance of this finding. The colon, predominantly the right side, was involved in 17 of the 18 cases. Pneumatosis intestinalis developed earlier in the 14 symptomatic patients than in the four asymptomatic patients. Symptoms included diarrhea (12 patients), abdominal pain (six patients), rectal bleeding (two patients), and abdominal distension (two patients). Factors contributing to the development of pneumatosis intestinalis included pretransplantation chemotherapy and radiotherapy, steroid therapy, infectious colitis, graft-versus-host disease, and septic shock. Intestinal disease contributed to the deaths of seven patients with pneumatosis intestinalis, necessitated right hemicolectomy in another patient, and resolved with conservative treatment in 10 patients. In summary, bone marrow transplant recipients with pneumatosis intestinalis may follow either a benign or fatal course, depending on the underlying condition of the patient. Clinical correlation is important in determining the significance of this finding.

Entities:  

Mesh:

Year:  1988        PMID: 3287869     DOI: 10.2214/ajr.151.1.85

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

1.  Management of pneumatosis coli with free intraperitoneal gas mimicking abdominal hollow organ perforation in a 13-year-old patient following bone marrow transplantation.

Authors:  Joachim Ruh; Giuliano Testa; Florian Von Deimling; Joerg Schaper; Bernhard Kremens; Christoph E Broelsch
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Pneumatosis cystoides intestinalis in relapsing polychondritis.

Authors:  Seung-Ki Kwok; Soo-Hong Seo; Hyun-Sook Kim; Ji Hyeon Ju; Chong-Hyeon Yoon; Sung-Hwan Park; Ho-Youn Kim
Journal:  Clin Rheumatol       Date:  2006-10-18       Impact factor: 2.980

3.  Pneumatosis intestinalis: cost paid for rheumatoid arthritis treatment.

Authors:  Pratyusha Tirumanisetty; Jose William Sotelo; Michael Disalle; Meenal Sharma
Journal:  BMJ Case Rep       Date:  2019-07-30

4.  Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.

Authors:  Hiroshi I Suzuki; Koji Izutsu; Takuro Watanabe; Kumi Oshima; Yoshinobu Kanda; Toru Motokura; Shigeru Chiba; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-06-17       Impact factor: 2.490

5.  Pneumoperitoneum without peritonitis.

Authors:  B D Daly; J A Guthrie; N F Couse
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

Review 6.  Pneumatosis intestinalis with Clostridium difficile colitis as a cause of acute abdomen after lung transplantation.

Authors:  P Schenk; C Madl; L Kramer; K Ratheiser; A Kranz; C Zauner; C Stain; T Birsan; W Klepetko; C Müller
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

7.  Alkyl halides, super hydrogen production and the pathogenesis of pneumatosis cystoides coli.

Authors:  T H Florin
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

8.  Asymptomatic pneumatosis intestinalis following chemotherapy for B lymphoblastic leukemia with recurrent genetic abnormalities in an adolescent patient.

Authors:  Dae-Kyu Shin; Jisu Oh; Harry Yoon; Jo Eun Kim; So Young Chong; Doyeun Oh
Journal:  Korean J Hematol       Date:  2012-03-28

9.  Benign pneumatosis intestinalis after bilateral lung transplantation.

Authors:  Florence Y Ling; Abdul Mueed Zafar; Luis F Angel; Amy L Mumbower
Journal:  BMJ Case Rep       Date:  2015-10-15

10.  Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT.

Authors:  P K Bhamidipati; A Ghobadi; S Bauer; J F DiPersio; I Pusic
Journal:  Bone Marrow Transplant       Date:  2014-07-21       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.